124 related articles for article (PubMed ID: 28125179)
1. An Approach to Optimise Therapeutic Vancomycin Dosage in a Haemodialysis Population.
Gunning H; Taylor G; Smyth A; Mellotte G; Fennell J; Murphy P; Lavin P; Wall C
Ir Med J; 2016 Oct; 109(9):465. PubMed ID: 28125179
[TBL] [Abstract][Full Text] [Related]
2. Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.
Vandecasteele SJ; De Bacquer D; De Vriese AS
Clin Infect Dis; 2011 Jul; 53(2):124-9. PubMed ID: 21690618
[TBL] [Abstract][Full Text] [Related]
3. Weight-based loading of vancomycin in patients on hemodialysis.
Brown M; Polisetty R; Gracely EJ; Cuhaci B; Schlecht HP
Clin Infect Dis; 2011 Jul; 53(2):164-6. PubMed ID: 21690623
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin dosing in patients on intermittent hemodialysis.
Vandecasteele SJ; De Vriese AS
Semin Dial; 2011; 24(1):50-5. PubMed ID: 21338394
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of vancomycin target trough attainment with published dosing regimens in the neonatal intensive care unit population.
Chung E; Lee SE; Abraham T; Saad NN; Gad A
J Neonatal Perinatal Med; 2019; 12(1):21-27. PubMed ID: 30149480
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C-Guided Vancomycin Dosing in Critically Ill Patients: A Quality Improvement Project.
Frazee E; Rule AD; Lieske JC; Kashani KB; Barreto JN; Virk A; Kuper PJ; Dierkhising RA; Leung N
Am J Kidney Dis; 2017 May; 69(5):658-666. PubMed ID: 28131530
[TBL] [Abstract][Full Text] [Related]
7. Maturational changes in vancomycin protein binding affect vancomycin dosing in neonates.
Leroux S; van den Anker JN; Smits A; Pfister M; Allegaert K
Br J Clin Pharmacol; 2019 May; 85(5):865-867. PubMed ID: 30834552
[No Abstract] [Full Text] [Related]
8. Dosage recommendation of vancomycin during haemodialysis with highly permeable membranes.
Zoer J; Schrander-van der Meer AM; van Dorp WT
Pharm World Sci; 1997 Aug; 19(4):191-6. PubMed ID: 9297732
[TBL] [Abstract][Full Text] [Related]
9. Initial vancomycin dosing protocol to achieve therapeutic serum concentrations in patients undergoing hemodialysis.
Zelenitsky SA; Ariano RE; McCrae ML; Vercaigne LM
Clin Infect Dis; 2012 Aug; 55(4):527-33. PubMed ID: 22573855
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors for Non-Therapeutic Initial Steady-State Vancomycin Trough Concentrations in Children and Adolescents Receiving High Empiric Doses of Intravenous Vancomycin.
Buckel WR; Ghobrial S; Tamma PD; Milstone AM; Zhao Y; Hsu AJ
Paediatr Drugs; 2017 Feb; 19(1):43-51. PubMed ID: 27873214
[TBL] [Abstract][Full Text] [Related]
11. Vancomycin administration during dialysis with low-flux polysulfone membranes: traditional versus a supplemental dosage regimen.
Stamatakis MK; Schreiber JM; Slain D; Gunel E
Am J Health Syst Pharm; 2003 Aug; 60(15):1564-8. PubMed ID: 12951755
[No Abstract] [Full Text] [Related]
12. Optimizing vancomycin dosage regimens in relation to high-flux haemodialysis.
Hui K; Patel K; Nalder M; Nelson C; Buising K; Pedagogos E; Kong DCM; Kirkpatrick CMJ
J Antimicrob Chemother; 2019 Jan; 74(1):130-134. PubMed ID: 30215721
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software.
Nunn MO; Corallo CE; Aubron C; Poole S; Dooley MJ; Cheng AC
Ann Pharmacother; 2011 Jun; 45(6):757-63. PubMed ID: 21652786
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a vancomycin dosing protocol for intensive care unit patients.
Brinkman I; Verstappen G; Veeger N; Boerma EC; Buter H
Neth J Med; 2015 May; 73(4):195-8. PubMed ID: 25968297
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin continuous infusion in neonates: dosing optimisation and therapeutic drug monitoring.
Zhao W; Lopez E; Biran V; Durrmeyer X; Fakhoury M; Jacqz-Aigrain E
Arch Dis Child; 2013 Jun; 98(6):449-53. PubMed ID: 23254142
[TBL] [Abstract][Full Text] [Related]
16. Preferable timing of therapeutic drug monitoring in patients with impaired renal function treated with once-daily administration of vancomycin.
Takahashi Y; Takesue Y; Takubo S; Ishihara M; Nakajima K; Tsuchida T; Ikeuchi H; Uchino M
J Infect Chemother; 2013 Aug; 19(4):709-16. PubMed ID: 23345049
[TBL] [Abstract][Full Text] [Related]
17. Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population.
Jarkowski A; Forrest A; Sweeney RP; Tan W; Segal BH; Almyroudis N; Wang ES; Wetzler M
J Oncol Pharm Pract; 2012 Mar; 18(1):91-6. PubMed ID: 21521799
[TBL] [Abstract][Full Text] [Related]
18. Vancomycin dosing nomogram for haemodialysis patients.
Jeremiah CJ; Wills C; Bayly A; Perry GJ; Davis JS; Tong SY; Currie BJ
Nephrology (Carlton); 2014 Aug; 19(8):513-4. PubMed ID: 25066142
[No Abstract] [Full Text] [Related]
19. Currently used dosage regimens of vancomycin fail to achieve therapeutic levels in approximately 40% of intensive care unit patients.
Obara VY; Zacas CP; Carrilho CM; Delfino VD
Rev Bras Ter Intensiva; 2016; 28(4):380-386. PubMed ID: 28099635
[TBL] [Abstract][Full Text] [Related]
20. Simple approach to improving vancomycin dosing in intensive care: a standardised loading dose results in earlier therapeutic levels.
Truong J; Levkovich BJ; Padiglione AA
Intern Med J; 2012 Jan; 42(1):23-9. PubMed ID: 22276559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
